Abstract 1619: ERK-targeted therapy suppresses tumorigenicity in ovarian clear cell carcinoma and is modulated by ERK-binding protein PEA-15
Oishi, Tetsuro, Bartholomeusz, Chandra, Kazansky, Anna, Akar, Ugur, Krishunamurthy, Savitori, Esteva, Francisco J., Itamochi, Hiroaki, Ueno, Naoto T.
Published in Cancer research (Chicago, Ill.) (15.04.2010)
Published in Cancer research (Chicago, Ill.) (15.04.2010)
Get full text
Journal Article